MozaffarianDBenjaminEJGoASet al.Heart disease and stroke statistics – 2015 update: A report from the American Heart Association. Circulation2015; 131: e29–e322.
2.
RoffiMPatronoCColletJPet al.2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevationTask Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J2016; 37: 267–315.
3.
SmallEMOlsonEN. Pervasive roles of microRNAs in cardiovascular biology. Nature2011; 469: 336–342.
4.
WideraCGuptaSKLorenzenJMet al.Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol2011; 51: 872–875.
5.
MalikRMushtaqueRSSiddiquiUAet al.Association between coronary artery disease and microRNA: Literature review and clinical perspective. Cureus2017; 9: e1188–e1188.
6.
ReddyLLShahSAPondeCKet al.Circulating miRNA-33: A potential biomarker in patients with coronary artery disease (CAD). Biomarkers2018; 19: 1–27.
7.
ChenBLuoLWeiXet al.Altered plasma miR-144 as a novel biomarker for coronary artery disease. Ann Clin Lab Sci2018; 48: 440–445.
8.
HortmannMWalterJEBenningLet al.Droplet digital PCR of serum miR-499, miR-21 and miR-208a for the detection of functionally relevant coronary artery disease. Int J Cardiol.. Epub ahead of print 14 August 2018. DOI: 10.1016/j.ijcard.2018.08.031.
